The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
Blauvelt, Andrew, Chiricozzi, Andrea
Published in Clinical reviews in allergy & immunology (01.12.2018)
Published in Clinical reviews in allergy & immunology (01.12.2018)
Get full text
Journal Article
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial
Blauvelt, Andrew, MD, MBA, Papp, Kim A., MD, PhD, Griffiths, Christopher E.M., MD, Randazzo, Bruce, MD, PhD, Wasfi, Yasmine, MD, PhD, Shen, Yaung-Kaung, PhD, Li, Shu, PhD, Kimball, Alexa B., MPH, MD
Published in Journal of the American Academy of Dermatology (01.03.2017)
Published in Journal of the American Academy of Dermatology (01.03.2017)
Get full text
Journal Article
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Simpson, Eric L, Bieber, Thomas, Guttman-Yassky, Emma, Beck, Lisa A, Blauvelt, Andrew, Cork, Michael J, Silverberg, Jonathan I, Deleuran, Mette, Kataoka, Yoko, Lacour, Jean-Philippe, Kingo, Külli, Worm, Margitta, Poulin, Yves, Wollenberg, Andreas, Soo, Yuhwen, Graham, Neil M.H, Pirozzi, Gianluca, Akinlade, Bolanle, Staudinger, Heribert, Mastey, Vera, Eckert, Laurent, Gadkari, Abhijit, Stahl, Neil, Yancopoulos, George D, Ardeleanu, Marius
Published in The New England journal of medicine (15.12.2016)
Published in The New England journal of medicine (15.12.2016)
Get full text
Journal Article
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
Reich, Kristian, Prof, Papp, Kim A, MD, Blauvelt, Andrew, MD, Tyring, Stephen K, Prof, Sinclair, Rodney, Prof, Thaçi, Diamant, Prof, Nograles, Kristine, MD, Mehta, Anish, BA, Cichanowitz, Nicole, MSJ, Li, Qing, PhD, Liu, Kenneth, PhD, La Rosa, Carmen, MD, Green, Stuart, MD, Kimball, Alexa B, Prof
Published in The Lancet (British edition) (15.07.2017)
Published in The Lancet (British edition) (15.07.2017)
Get full text
Journal Article
Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)
Blauvelt, Andrew, Gooderham, Melinda, Iversen, Lars, Ball, Susan, Zhang, Lu, Agada, Noah O., Reich, Kristian
Published in Journal of the American Academy of Dermatology (01.11.2017)
Published in Journal of the American Academy of Dermatology (01.11.2017)
Get full text
Journal Article
Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis
Kagami, Shinji, Rizzo, Heather L., Lee, Jennifer J., Koguchi, Yoshinobu, Blauvelt, Andrew
Published in Journal of investigative dermatology (01.05.2010)
Published in Journal of investigative dermatology (01.05.2010)
Get full text
Journal Article
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial
Thaçi, Diamant, MD, Blauvelt, Andrew, MD, MBA, Reich, Kristian, MD, Tsai, Tsen-Fang, MD, Vanaclocha, Francisco, MD, Kingo, Külli, MD, PhD, Ziv, Michael, MD, BSc, Pinter, Andreas, MD, Hugot, Sophie, MSc, You, Ruquan, MSc, Milutinovic, Marina, MD
Published in Journal of the American Academy of Dermatology (01.09.2015)
Published in Journal of the American Academy of Dermatology (01.09.2015)
Get full text
Journal Article
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study
Blauvelt, Andrew, MD, MBA, Reich, Kristian, MD, Tsai, Tsen-Fang, MD, Tyring, Stephen, MD, PhD, Vanaclocha, Francisco, MD, Kingo, Külli, MD, PhD, Ziv, Michael, MD, BSc, Pinter, Andreas, MD, Vender, Ronald, MD, FRCPC, Hugot, Sophie, MSc, You, Ruquan, MSc, Milutinovic, Marina, MD, Thaçi, Diamant, MD
Published in Journal of the American Academy of Dermatology (01.01.2017)
Published in Journal of the American Academy of Dermatology (01.01.2017)
Get full text
Journal Article
Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis
van de Kerkhof, Peter C.M., MD, PhD, Griffiths, Christopher E.M., MD, Reich, Kristian, MD, PhD, Leonardi, Craig L., MD, Blauvelt, Andrew, MD, MBA, Tsai, Tsen-Fang, MD, Gong, Yankun, PhD, Huang, Jiaqing, MD, PhD, Papavassilis, Charis, MD, PhD, Fox, Todd, RPh, PharmB, ACPR
Published in Journal of the American Academy of Dermatology (01.07.2016)
Published in Journal of the American Academy of Dermatology (01.07.2016)
Get full text
Journal Article
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
Gordon, Kenneth B, Blauvelt, Andrew, Papp, Kim A, Langley, Richard G, Luger, Thomas, Ohtsuki, Mamitaro, Reich, Kristian, Amato, David, Ball, Susan G, Braun, Daniel K, Cameron, Gregory S, Erickson, Janelle, Konrad, Robert J, Muram, Talia M, Nickoloff, Brian J, Osuntokun, Olawale O, Secrest, Roberta J, Zhao, Fangyi, Mallbris, Lotus, Leonardi, Craig L
Published in The New England journal of medicine (28.07.2016)
Published in The New England journal of medicine (28.07.2016)
Get full text
Journal Article
Clinical meaningfulness of complete skin clearance in psoriasis
Strober, Bruce, MD, PhD, Papp, Kim A., MD, PhD, Lebwohl, Mark, MD, Reich, Kristian, MD, Paul, Carle, MD, PhD, Blauvelt, Andrew, MD, Gordon, Kenneth B., MD, Milmont, Cassandra E., PhD, Viswanathan, Hema N., PhD, Li, Joanne, PhD, Pinto, Lionel, PhD, Harrison, David J., PhD, Kricorian, Greg, MD, Nirula, Ajay, MD, PhD, Klekotka, Paul, MD, PhD
Published in Journal of the American Academy of Dermatology (01.07.2016)
Published in Journal of the American Academy of Dermatology (01.07.2016)
Get full text
Journal Article
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
Thaçi, Diamant, Prof, Simpson, Eric L, MD, Beck, Lisa A, Prof, Bieber, Thomas, Prof, Blauvelt, Andrew, MD, Papp, Kim, MD, Soong, Weily, MD, Worm, Margitta, Univ-Prof, Szepietowski, Jacek C, Prof, Sofen, Howard, MD, Kawashima, Makoto, Prof, Wu, Richard, PhD, Weinstein, Steven P, MD, Graham, Neil M H, MD, Pirozzi, Gianluca, MD, Teper, Ariel, MD, Sutherland, E Rand, MD, Mastey, Vera, MS, Stahl, Neil, PhD, Yancopoulos, George D, MD, Ardeleanu, Marius, MD
Published in The Lancet (British edition) (02.01.2016)
Published in The Lancet (British edition) (02.01.2016)
Get full text
Journal Article
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments
Gelfand, Joel M., Armstrong, April W., Bell, Stacie, Anesi, George L., Blauvelt, Andrew, Calabrese, Cassandra, Dommasch, Erica D., Feldman, Steven R., Gladman, Dafna, Kircik, Leon, Lebwohl, Mark, Lo Re, Vincent, Martin, George, Merola, Joseph F., Scher, Jose U., Schwartzman, Sergio, Treat, James R., Van Voorhees, Abby S., Ellebrecht, Christoph T., Fenner, Justine, Ocon, Anthony, Syed, Maha N., Weinstein, Erica J., Gondo, George, Heydon, Sue, Koons, Samantha, Ritchlin, Christopher T.
Published in Journal of the American Academy of Dermatology (01.05.2021)
Published in Journal of the American Academy of Dermatology (01.05.2021)
Get full text
Journal Article
Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)
Simpson, Eric L., MD, MCR, Gadkari, Abhijit, PhD, Worm, Margitta, MD, Soong, Weily, MD, Blauvelt, Andrew, MD, MBA, Eckert, Laurent, PhD, Wu, Richard, PhD, Ardeleanu, Marius, MD, Graham, Neil M.H., MD, PhD, Pirozzi, Gianluca, MD, PhD, Sutherland, E. Rand, MD, MPH, Mastey, Vera, BPharm, MS
Published in Journal of the American Academy of Dermatology (01.09.2016)
Published in Journal of the American Academy of Dermatology (01.09.2016)
Get full text
Journal Article
Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis
Harper, Erin G., Guo, Changsheng, Rizzo, Heather, Lillis, Joseph V., Kurtz, Stephen E., Skorcheva, Iliyana, Purdy, David, Fitch, Erin, Iordanov, Mihail, Blauvelt, Andrew
Published in Journal of investigative dermatology (01.09.2009)
Published in Journal of investigative dermatology (01.09.2009)
Get full text
Journal Article
A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)
Gelfand, Joel M., Shin, Daniel B., Duffin, Kristina Callis, Armstrong, April W., Blauvelt, Andrew, Tyring, Stephen K., Menter, Alan, Gottlieb, Scott, Lockshin, Benjamin N., Simpson, Eric L., Kianifard, Farid, Sarkar, Rajendra Prasad, Muscianisi, Elisa, Steadman, Jennifer, Ahlman, Mark A., Playford, Martin P., Joshi, Aditya A., Dey, Amit K., Werner, Thomas J., Alavi, Abass, Mehta, Nehal N.
Published in Journal of investigative dermatology (01.09.2020)
Published in Journal of investigative dermatology (01.09.2020)
Get full text
Journal Article
IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A
Rizzo, Heather L, Kagami, Shinji, Phillips, Kevin G, Kurtz, Stephen E, Jacques, Steven L, Blauvelt, Andrew
Published in The Journal of immunology (1950) (01.02.2011)
Published in The Journal of immunology (1950) (01.02.2011)
Get full text
Journal Article
Lymphatic Dysfunction Exacerbates Cutaneous Tumorigenesis and Psoriasis-Like Skin Inflammation through Accumulation of Inflammatory Cytokines
Boki, Hikari, Kimura, Takayuki, Miyagaki, Tomomitsu, Suga, Hiraku, Blauvelt, Andrew, Okochi, Hitoshi, Sugaya, Makoto, Sato, Shinichi
Published in Journal of investigative dermatology (01.06.2022)
Published in Journal of investigative dermatology (01.06.2022)
Get full text
Journal Article